Reported 0 shares, down 2,628,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 4901000 |
| 2022-03-31 | 4665000 |
| 2022-06-30 | 1475000 |
| 2022-09-30 | 1750000 |
| 2022-12-31 | 3135000 |
| 2023-03-31 | 38362768 |
| 2023-06-30 | 48194147 |
| 2023-09-30 | 61503750 |
| 2023-12-31 | 62073360 |
| 2024-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2024 | Reduced | 0 | -2,628,000 (-100.0%) | 0 | $0 | 2024-05-15 | |
| Q4 2023 | Reduced | 2,628,000 | -1,497,000 (-36.3%) | 0.13% | $62,073,360 | 2024-02-14 | |
| Q3 2023 | Reduced | 4,125,000 | -276,292 (-6.3%) | 0.14% | $61,503,750 | 2023-11-14 | |
| Q2 2023 | Added | 4,401,292 | +1,892 (0.0%) | 0.1% | $48,194,147 | 2023-08-14 | |
| Q1 2023 | Added | 4,399,400 | +3,899,400 (779.9%) | 0.09% | $38,362,768 | 2023-05-15 | |
| Q4 2022 | Unchanged | 500,000 | 0 (0.0%) | < 0.01% | $3,135,000 | 2023-02-14 | |
| Q3 2022 | Unchanged | 500,000 | 0 (0.0%) | < 0.01% | $1,750,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 500,000 | -1,000,000 (-66.7%) | < 0.01% | $1,475,000 | 2022-08-15 | |
| Q1 2022 | Added | 1,500,000 | +50,000 (3.4%) | < 0.01% | $4,665,000 | 2022-05-16 | |
| Q4 2021 | Unchanged | 1,450,000 | 0 (0.0%) | < 0.01% | $4,901,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
200 managers reported CYMABAY THERAPEUTICS INC for Q1 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| IFP Advisors Inc | Unchanged | 650 | 0 | < 0.01% | $21,077 | 19 qtrs |
| GREAT WEST LIFE ASSURANCE CO CAN | Reduced | 0 | -8,424 | 0 | $0 | 5 qtrs |
| VICTORY CAPITAL MANAGEMENT INC | Reduced | 0 | -689,603 | 0 | $0 | 5 qtrs |
| Hennion & Walsh Asset Management Inc | Reduced | 0 | -78,311 | 0 | $0 | 4 qtrs |
| Metropolitan Life Insurance Co NY | Reduced | 0 | -6,447 | 0 | $0 | 4 qtrs |
| Novo Holdings A S | Reduced | 0 | -900,000 | 0 | $0 | 4 qtrs |
| J Goldman & Co LP | Reduced | 0 | -165,937 | 0 | $0 | 3 qtrs |
| Harvest Fund Management Co Ltd | Reduced | 0 | -1,076 | 0 | $0 | 2 qtrs |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Reduced | 0 | -68,457 | 0 | $0 | 20 qtrs |
| AMERIPRISE FINANCIAL INC | Reduced | 0 | -25,711 | 0 | $0 | 2 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2024
- Filed
- May 15, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.